Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses

Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses

Abstract Background PALETTE is a phase 3 trial that demonstrated single-agent activity of pazopanib in advanced soft tissue sarcomas (aSTS). We performed retrospective subgroup analyses to explore potential relationships between patient characteristics, prior lines of therapy, dose intensity, and do...

Full description

Bibliographic Details
Main Authors: Axel Le Cesne, Sebastian Bauer, George D. Demetri, Guangyang Han, Luca Dezzani, Qasim Ahmad, Jean-Yves Blay, Ian Judson, Patrick Schöffski, Massimo Aglietta, Peter Hohenberger, Hans Gelderblom
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Cancer
Subjects:
Pazopanib
Advanced soft tissue sarcoma
Progression-free survival
PALETTE subgroup analysis
Online Access:http://link.springer.com/article/10.1186/s12885-019-5988-3

Internet

http://link.springer.com/article/10.1186/s12885-019-5988-3

Similar Items